Freshfields Bruckhaus Deringer
Freshfields advises in Ocean Deal Dive Paid Members Public
In Short: Lloyd’s Register is buying a majority stake in Ocean Technologies Group (OTG) from private equity firm Oakley Capital for £50 million. The acquisition will boost Lloyd’s Register’s maritime technology and services portfolio, with a particular focus on training for sustainable maritime practices.
Freshfields and Clifford Chance Advise on UCB’s $680 Million Sale Paid Members Public
In Short: Belgian biopharma giant UCB is selling its portfolio of established products in China, including epilepsy drug Keppra and antihistamine Zyrtec, to Singapore's CBC Group and Abu Dhabi’s Mubadala Investment Co. for $680 million. This move allows UCB to focus on developing new medicines in China,
Freshfields and Linklaters Advise on HgCapital’s £24.3M Exit from TeamSystem to Hellman & Friedman Paid Members Public
In Short: British investment firm HgCapital is selling its remaining interest in TeamSystem to U.S. private equity firm Hellman & Friedman, securing approximately £24.3 million.
JP Morgan's Joint Venture Showdown Paid Members Public
In Short: J.P. Morgan didn’t try to lowball the value of Viva Wallet, a London judge decided, wrapping up the spat with Werealize over who gets to buy out whom.
